Healthpeak Properties Future Growth

Future criteria checks 1/6

Healthpeak Properties's earnings are forecast to decline at 0.3% per annum while its annual revenue is expected to grow at 11.3% per year. EPS is expected to decline by 5.5% per annum. Return on equity is forecast to be 6.2% in 3 years.

Key information

-0.3%

Earnings growth rate

-5.5%

EPS growth rate

Health Care REITs earnings growth	16.0%
Revenue growth rate	11.3%
Future return on equity	6.2%
Analyst coverage	Good
Last updated	25 Apr 2024

Recent future growth updates

Recent updates

HealthPeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth

Apr 12

Healthpeak Properties FFO of $0.44 beats by $0.01, revenue of $524.47M beats by $5.62M

Feb 07

Healthpeak Properties declares $0.30 dividend

Feb 01

Healthpeak prices $400M notes offering

Jan 09

Healthpeak Properties Q3 2022 Earnings Preview

Oct 31

Healthpeak Properties: A Smart Income Stock Flying Under The Radar

Sep 19

Healthpeak Properties: There Are Still Better Prospects Right Now

Jul 06

Healthpeak Properties, Inc.: Steady Dividend, Poor Price Growth, High Price Multiples

Apr 21

Healthpeak Properties: Too Lofty Still

Feb 13

Healthpeak Properties: Your Easy Button To Gain Diversified Healthcare Exposure

Dec 04

Healthpeak Rationalizes Its Holdings, Provides Strong Outlook

Sep 18

Analysts Just Made A Huge Upgrade To Their Healthpeak Properties, Inc. (NYSE:PEAK) Forecasts

Aug 07

Healthpeak Properties (PEAK) Investor Presentation - Slideshow

Jun 16

Earnings and Revenue Growth Forecasts

NYSE:DOC - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	2,969	226	337	1,198	2
12/31/2025	2,899	381	242	1,124	7
12/31/2024	2,690	245	982	1,731	8
12/31/2023	2,181	304	956	956	N/A
9/30/2023	2,152	239	932	932	N/A
6/30/2023	2,116	530	922	922	N/A
3/31/2023	2,088	543	880	880	N/A
12/31/2022	2,061	495	900	900	N/A
9/30/2022	2,020	514	917	917	N/A
6/30/2022	1,981	213	885	885	N/A
3/31/2022	1,939	312	867	867	N/A
12/31/2021	1,896	117	795	795	N/A
9/30/2021	1,845	68	790	790	N/A
6/30/2021	1,787	-17	798	798	N/A
3/31/2021	1,719	-125	786	786	N/A
12/31/2020	1,645	144	758	758	N/A
9/30/2020	988	326	757	757	N/A
6/30/2020	1,102	311	785	785	N/A
3/31/2020	1,185	240	783	783	N/A
12/31/2019	1,240	159	846	846	N/A
9/30/2019	1,908	831	844	844	N/A
6/30/2019	1,826	976	790	790	N/A
3/31/2019	1,804	1,080	811	811	N/A
12/31/2018	1,191	822	849	849	N/A
9/30/2018	1,848	169	842	842	N/A
6/30/2018	1,846	62	855	855	N/A
3/31/2018	1,835	-8	850	850	N/A
12/31/2017	1,848	413	847	847	N/A
9/30/2017	1,945	549	N/A	853	N/A
6/30/2017	2,022	599	N/A	979	N/A
3/31/2017	2,101	774	N/A	1,139	N/A
12/31/2016	2,129	361	N/A	1,214	N/A
9/30/2016	1,655	384	N/A	1,353	N/A
6/30/2016	1,781	456	N/A	1,295	N/A
3/31/2016	1,850	427	N/A	1,261	N/A
12/31/2015	1,940	139	N/A	1,216	N/A
9/30/2015	2,478	235	N/A	1,233	N/A
6/30/2015	2,418	367	N/A	1,235	N/A
3/31/2015	2,347	421	N/A	1,232	N/A
12/31/2014	1,637	255	N/A	1,249	N/A
9/30/2014	2,193	927	N/A	1,188	N/A
6/30/2014	2,143	903	N/A	1,185	N/A
3/31/2014	2,119	895	N/A	1,182	N/A
12/31/2013	2,100	895	N/A	1,149	N/A
9/30/2013	2,079	875	N/A	1,158	N/A
6/30/2013	2,000	841	N/A	1,123	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DOC's earnings are forecast to decline over the next 3 years (-0.3% per year).

Earnings vs Market: DOC's earnings are forecast to decline over the next 3 years (-0.3% per year).

High Growth Earnings: DOC's earnings are forecast to decline over the next 3 years.

Revenue vs Market: DOC's revenue (11.3% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: DOC's revenue (11.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: DOC's Return on Equity is forecast to be low in 3 years time (6.2%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Healthpeak Properties Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Consensus EPS estimates fall by 11%, revenue upgraded

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2024

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2023

Consensus EPS estimates increase by 14%

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2023

Consensus forecasts updated

Recent updates

HealthPeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth

Healthpeak Properties, Inc. to Report Q1, 2024 Results on Apr 25, 2024

New major risk - Revenue and earnings growth

New minor risk - Shareholder dilution

Healthpeak Properties, Inc., Annual General Meeting, Apr 25, 2024

Consensus EPS estimates fall by 11%, revenue upgraded

Healthpeak Properties, Inc. (NYSE:PEAK) completed the acquisition of Physicians Realty Trust (NYSE:DOC) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., State Street Corporation (NYSE:STT) and others.

Healthpeak Properties: Undervalued With Strong Fundamentals

Healthpeak Properties, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS exceeds analyst expectations

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2024

Upcoming dividend of US$0.30 per share at 6.7% yield

Third quarter dividend of US$0.30 announced

Healthpeak Properties, Inc. to Report Q4, 2023 Results on Feb 08, 2024

New major risk - Revenue and earnings growth

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend, Payable on February 26, 2024

Healthpeak Opportunistically Cheap As Supply Moderates

Healthpeak Properties, Inc. (NYSE:PEAK) entered into a definitive agreement to acquire Physicians Realty Trust (NYSE:DOC) for approximately $2.7 billion in a merger of equals transaction.

Healthpeak Properties: 7.2% Yielding SWAN

Healthpeak Properties, Inc. to Report Q3, 2023 Results on Oct 30, 2023

Healthpeak Properties: A Safe 6.9% Yield

Healthpeak Is Both Undervalued And Undercovered - And A 'Buy'

Second quarter 2023 earnings: EPS misses analyst expectations

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2023

Healthpeak Properties: 6% Yield, Profit From Market Absurdity

Healthpeak Properties, Inc. to Report Q2, 2023 Results on Jul 27, 2023

Consensus EPS estimates increase by 14%

First quarter 2023 earnings: EPS exceeds analyst expectations

Independent Director recently bought US$86k worth of stock

High number of new directors

Now 24% undervalued after recent price drop

CEO, President & Director recently bought US$385k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Healthpeak Properties, Inc. Provides Earnings Guidance for the Full Year 2023

Healthpeak Properties FFO of $0.44 beats by $0.01, revenue of $524.47M beats by $5.62M

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend, Payable on February 23, 2023

Healthpeak Properties declares $0.30 dividend

Healthpeak Properties, Inc. to Report Q4, 2022 Results on Feb 07, 2023

Consensus forecasts updated

Healthpeak prices $400M notes offering

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2022

Third quarter 2022 earnings: EPS exceeds analyst expectations

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2022

Healthpeak Properties Q3 2022 Earnings Preview

Healthpeak Properties, Inc. Declares Quarterly Cash Dividend, Payable on November 18, 2022

High number of new directors

Healthpeak Properties Announces Management Changes

Healthpeak Properties, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Healthpeak Properties: A Smart Income Stock Flying Under The Radar

Healthpeak Properties, Inc. (NYSE:PEAK) announces an Equity Buyback for $500 million worth of its shares.

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Healthpeak Properties, Inc. (NYSE:PEAK) announces an Equity Buyback for $500 million worth of its shares.

Healthpeak Properties, Inc. Revises Earnings Guidance for the Year 2022

Healthpeak Properties Declares Quarterly Cash Dividend on Common Stock, Payable on August 19, 2022

Healthpeak Properties, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Healthpeak Properties, Inc. Announces the Resignation of Lydia H. Kennard from the Board of Directors

Healthpeak Properties: There Are Still Better Prospects Right Now

Investor sentiment deteriorated over the past week

Healthpeak Properties, Inc. (NYSE:PEAK) acquired Two Medical Office Buildings Located in Houston for $43 million

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Healthpeak Properties, Inc.: Steady Dividend, Poor Price Growth, High Price Multiples

Healthpeak Properties, Inc. to Report Q1, 2022 Results on May 03, 2022

Healthpeak Properties: Too Lofty Still

Full year 2021 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates increase by 12%

Healthpeak Properties, Inc. Provides Earnings Guidance for the Fiscal Year 2022

Upcoming dividend of US$0.30 per share

Healthpeak Properties, Inc. Declares Quarterly Common Stock Cash Dividend, Payable on February 22, 2022

Healthpeak Properties: Your Easy Button To Gain Diversified Healthcare Exposure